Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer. | Cancers (Basel) | 2023 | 36900394 | PubTator, text mining | PubMed |
| Emerging Therapies in CLL in the Era of Precision Medicine. | Cancers (Basel) | 2023 | 36900373 | PubTator, text mining | PubMed |
| Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution. | Cancers (Basel) | 2023 | 36900178 | PubTator, text mining | PubMed |
| Molecular mechanism and diagnostic marker investigation of endoplasmic reticulum stress on periodontitis. | BMC Oral Health | 2023 | 36894919 | PubTator, text mining | PubMed |
| Vinyl chloride enhances high-fat diet-induced proteome alterations in the mouse pancreas related to metabolic dysfunction. | Toxicol Sci | 2023 | 36892438 | PubTator, text mining | PubMed |
| Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. | NPJ Vaccines | 2023 | 36890168 | PubTator, text mining | PubMed |
| Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. | Cardiovasc Res | 2023 | 36883593 | PubTator, text mining | PubMed |
| Emerging phagocytosis checkpoints in cancer immunotherapy. | Signal Transduct Target Ther | 2023 | 36882399 | PubTator, text mining | PubMed |
| Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort. | Clin Epigenetics | 2023 | 36855205 | PubTator, text mining | PubMed |
| Retrospective screening of serum IgG glycosylation biomarker for primary Sjögren's syndrome using lectin microarray. | PeerJ | 2023 | 36852221 | PubTator, text mining | PubMed |
| Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis. | Elife | 2023 | 36848406 | PubTator, text mining | PubMed |
| Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects. | Front Immunol | 2023 | 36845153 | PubTator, text mining | PubMed |
| HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks. | Onco Targets Ther | 2023 | 36844609 | PubTator, text mining | PubMed |
| Differentially Expressed Genes and Molecular Susceptibility to Human Age-Related Diseases. | Int J Mol Sci | 2023 | 36835409 | PubTator, text mining | PubMed |
| In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines. | Cells | 2023 | 36831263 | PubTator, text mining | PubMed |
| The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells. | J Leukoc Biol | 2023 | 36822164 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with macrophage infiltration in non-obstructive azoospermia using single-cell transcriptomic and microarray data. | Ann Transl Med | 2023 | 36819497 | PubTator, text mining | PubMed |
| Neuroglia Cells Transcriptomic in Brain Development, Aging and Neurodegenerative Diseases. | Aging Dis | 2023 | 36818562 | PubTator, text mining | PubMed |
| Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA. | Front Immunol | 2023 | 36817447 | PubTator, text mining | PubMed |
| Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV. | JCI Insight | 2023 | 36805331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=28